Adicet bio to participate in fireside chat at jmp securities hematology summit

Menlo park, calif., dec. 08, 2020 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing first-in-class allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that chen schor, president and chief executive officer and stewart abbot, ph.d., chief scientific and operating officer, will participate in a fireside chat at the jmp securities hematology summit on tuesday, december 15, 2020 at 2:00 pm et.
ACET Ratings Summary
ACET Quant Ranking